CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway

CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space

(2022) Jan Korbecki et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

FOXQ1-mediated SIRT1 upregulation enhances stemness and radio-resistance of colorectal cancer cells and restores intestinal microbiota function by promoting β-catenin nuclear translocation

(2022) Mei Yang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

PMN-MDSCs accumulation induced by CXCL1 promotes CD8+ T cells exhaustion in gastric cancer

(2022) Xingyu Zhou et al.   CANCER LETTERS

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer

(2021) Rhynelle S. Dmello et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer

(2021) Jing Yu et al.   Frontiers in Oncology

Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol

(2019) Constanze Buhrmann et al.   Nutrients

Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer

(2019) Zhongsheng Peng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer

(2018) Changhua Zhuo et al.   BIOSCIENCE REPORTS

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy

(2018) Jinyang Li et al.   IMMUNITY

CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling

(2018) Neng Wang et al.   Cell Death & Disease

CXCL1 Inhibition Regulates UVB-Induced Skin Inflammation and Tumorigenesis in Xpa -Deficient Mice

(2017) Makoto Kunisada et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Curcumin Inhibits 5-Fluorouracil-induced Up-regulation of CXCL1 and CXCL2 of the Colon Associated with Attenuation of Diarrhoea Development

(2016) Hiroyasu Sakai et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression

(2016) Lena Seifert et al.   NATURE

ERK5 Is a Critical Mediator of Inflammation-Driven Cancer

(2015) K. G. Finegan et al.   CANCER RESEARCH

Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition

(2013) Feng Wang et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

CXCL1/GROα increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-κB/HDAC1 epigenetic regulation

(2012) Po-Lin Kuo et al.   CARCINOGENESIS

Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer

(2011) Hai-Bo Han et al.   JOURNAL OF PATHOLOGY

Macrophages limit chemotherapy

(2011) Michele De Palma et al.   NATURE

Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers

(2008) K. Imai et al.   CLINICAL CANCER RESEARCH